 |
Esprit Pharma, Inc. to be aquired by Allergan, Inc.
more
 |
|
Esprit Pharma Secures Marketing Rights to SANCTURAŽ XR
more
|
|
Esprit Pharma Elects Robert E. Baldini to Its Board of Directors
more
|
|
Esprit Pharma Successfully Completes a Series
B Financing, Raising in Excess of $90 Million
more
|
|
Esprit Pharma Acquires Exclusive North American Rights
to Novel Treatment for HSDD in Women
more
|
|
Esprit Pharma Appoints Vice President of
Trade
more
|
|
Esprit Pharma Secures $50 Million Credit Facility,
Further Positioning Itself to Build Upon Current Growth Momentum
more
|
|
Esprit Pharma Acquired Exclusive North America
Rights to ESTRASORB® Topical Emulsion
more
|
|
Esprit Pharma Acquires Metagen Pharmaceuticals
more
|
|
Esprit Pharma appoints Christopher Dowd Senior Vice President,
Sales
more
|
|
Depomed and Esprit Enter into License Agreement for Proquin(™)
XR
more
|
|
Esprit Pharma acquires U.S. rights to Sanctura, a treatment
for overactive bladder
more
|
